febit to Receive Funding from a Federal Grant Awarded in the German Excellence Cluster Contest
News Feb 11, 2009
As early as mid-February, febit will start setting up the Biomarker Discovery Center Heidelberg, one of the projects recently awarded funding from the Excellence Cluster Initiative of the German Federal Ministry of Education and Research (BMBF).
Together, the projects of the companies involved in the Biotech Excellence Cluster Rhine-Neckar were granted a total of 40 million Euros for the development of innovative drugs, diagnostics and technologies in cellular and molecular biology.
febit convinced the jury with two projects: in mid-February febit will start combining microarray technology and high-throughput sequencing (Next Generation Sequencing) to create powerful and cost-effective procedures for the development and validation of novel biomarkers.
The second project aims at the determination of novel tumor markers. Collaborating with the German Cancer Research Center (DKFZ), febit will conduct studies directed at the identification of markers for various cancer types and develop these into standardized diagnostic assays in the near future.
“We are pleased that the grant gives us the opportunity to initiate these scientifically advanced projects. febit´s highly versatile and equally automatable technology is ideally suited for the use in diagnostics requiring individual investigations with standardized procedures,“ explains febit CSO Peer Stahler.
This particular technology will be able to identify candidate markers which are then statistically analyzed by a package of software algorithms. A novel DNA enrichment technology will capture samples for high-throughput sequencing machines, thus allowing rapid and efficient characterization of genes involved in tumor formation.
About 422 million people around the world, including more than 30 million Americans, have diabetes. Obesity is the most significant risk factor for type 2 diabetes. yet about 30 percent of obese people do not develop type 2 diabetes or other metabolic conditions. New research aims to understand on a cellular level, how this separation occurs.READ MORE
Measuring hand grip can help identify youths who could benefit from lifestyle changes, says new research. While other studies have shown that muscle weakness as measured by grip strength is a predictor of unhealthy outcomes - including cardiovascular and metabolic diseases - this is the first to do so for adolescent health over time.READ MORE
Virtually all functions in our bodies require precise interactions between radically different types of molecules. A new study aims to understand how RNA molecules pair with intended protein partners. Researchers hope that they eventually will be able to predict and manipulate these partnerships that have been carved through millions of years of evolution.READ MORE